Latest News

BrightSpring Health Services: recent performance snapshot BrightSpring Health Services (BTSG) has drawn attention after a mixed stretch in its share price, with a 1% decline over the past month and an approximately 19% gain in the past 3 months. See our latest analysis for BrightSpring Health Services. At a share price of US$38.46, BrightSpring’s recent 1 day and 1 week share price returns are modestly negative, but a 90 day share price return of 19.22% and a 1 year total shareholder return...

Why the Ramco MoU matters for Singapore Technologies Engineering Singapore Technologies Engineering (SGX:S63) just entered a Memorandum of Understanding with Ramco Systems to explore a long-term partnership focused on digital and AI-enabled aviation MRO solutions. The plan includes assessing a jointly operated Competency Centre and Innovation Lab in Singapore, which could influence how investors think about the group’s commercial aerospace capabilities and future technology roadmap. See our...

What Shopify’s recent performance tells you right now Shopify (SHOP) has been on many investors’ radars after a stretch of weak returns, with the stock down about 27% over the past month and 22% over the past 3 months. See our latest analysis for Shopify. The recent 7 day share price return of 10.76% decline and year to date share price return of 27.77% decline suggest momentum has faded, even though the 3 year total shareholder return of about 174% still reflects a strong longer term...

Sonoco Products (SON) closed out FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$3.51, alongside net income from continuing operations of US$349.6 million, setting a clear marker for how the year finished. Over the last few quarters, the company has seen revenue move from US$1.4 billion and EPS of US$0.57 in Q4 2024 to US$1.7 billion and EPS of US$0.50 in Q1 2025, then US$1.9 billion and EPS of US$0.69 in Q2 2025, before reaching US$2.1 billion and EPS of US$1.24 in...

HIVE Digital Technologies (TSXV:HIVE) has just reported Q3 2026 results that pair US$93.1 million in revenue with a basic EPS loss of US$0.38, and most investors will immediately set those figures against the company’s recent swing from a US$0.19 EPS profit in Q1 2026 to a US$0.07 loss in Q2 and now a deeper loss in Q3. Over the past few quarters the business has seen revenue move from US$22.6 million in Q2 2025 to US$29.2 million in Q3 2025, US$31.2 million in Q4 2025, US$45.6 million in Q1...

PDD Holdings recently came under scrutiny as analysts highlighted rising domestic competition, regulatory challenges, and higher expenses that are weighing on its profitability and core retail performance. At the same time, many analysts still point to PDD’s ecosystem strengths and international platforms like Temu as supporting its longer-term business potential despite these pressures. We’ll now explore how mounting regulatory and competitive pressures may alter PDD Holdings’ previously...

Recent commentary around CarGurus (CARG) centers on softer marketplace trends, with modest 2.5% annual growth in paying dealers and an 8.1% annual decline in average revenue per user, which points to ongoing demand and retention challenges. See our latest analysis for CarGurus. CarGurus’ share price has softened over 2025, with a 30 day share price return of 18.85% and a year to date share price return of 26.35%. The 1 year total shareholder return is 30.57% and the 3 year total shareholder...

Itron, Inc. reported past fourth-quarter 2025 results with revenue of US$571.66 million versus US$612.86 million a year earlier, while net income rose to US$101.63 million from US$58.11 million and full-year diluted EPS from continuing operations increased to US$6.50 from US$5.18. The company paired this record profitability with 2026 guidance calling for US$2.35 billion–US$2.45 billion in revenue and highlighted high-margin contributions from its new Resiliency Solutions segment built...

Genuine Parts (GPC) has wrapped up FY 2025 with Q4 revenue of US$6.0b and a basic EPS loss of US$4.39, as net income excluding extra items came in at a loss of US$609.5m. Across the last six reported quarters, the company has seen quarterly revenue move from US$5.8b in Q4 2024 to US$6.3b in Q3 2025 and then US$6.0b in Q4 2025, while basic EPS has ranged from US$0.96 in Q4 2024 to US$1.83 in Q2 2025 before the most recent loss. For investors, the focus this season is on how these revenue...

Altria Group has pulled its NJOY Ace e vapor device from U.S. stores due to regulatory issues. The decision affects Altria's push into smoke free products and its presence in the nicotine alternatives market. Investors are assessing what this means for NYSE:MO and the role of reduced risk products in the company's plans. For investors watching NYSE:MO, this move comes at a time when the stock is trading around $66.54 with a reported 1 year return of 35.2% and a 5 year return of 121.8%...

Huron Consulting Group (HURN) has rolled out a wide wave of executive promotions across healthcare, digital, financial advisory, education, and research, spotlighting its focus on senior talent and specialised capabilities in key client segments. See our latest analysis for Huron Consulting Group. At a share price of US$130.21, Huron’s 1 month share price return of 29.03% decline and year to date share price return of 23.88% decline contrast with a 5 year total shareholder return of 122.39%...

Armada Hoffler Properties (AHH) has just posted its FY 2025 numbers with third quarter revenue of US$96.1 million, a basic EPS loss of US$0.04, and funds from operations of US$20.2 million, giving investors a fresh read on both top line scale and REIT specific cash generation. Across recent quarters, revenue has moved from US$184.7 million in Q2 2024 to US$142.8 million in Q4 2024 and then to US$112.7 million, US$100.9 million, and US$96.1 million in Q1, Q2, and Q3 2025 respectively, while...

PTC Therapeutics, Inc. (NasdaqGS:PTCT) has withdrawn its planned resubmission of the New Drug Application for Translarna following feedback from the US Food and Drug Administration. The decision affects Translarna's potential US path for treating patients with Duchenne muscular dystrophy caused by nonsense mutations. The update centers on regulatory communication, not on new clinical data releases. PTC Therapeutics focuses on therapies for rare diseases, so each regulatory decision can...

Granite Construction recently reported its fourth-quarter and full-year 2025 results, showing higher sales and earnings from continuing operations, while also announcing a new US$19.00 million preconstruction services agreement for Nevada’s I-80 East Widening Project and affirming a quarterly dividend of US$0.13 per share. The combination of record US$7.00 billion backlog, expanding vertically integrated materials operations through acquisitions, and the I-80 Progressive Design-Build award...

Recent scrutiny of Quantum Computing (QUBT) has centered on its very small reported revenues, heavy cash use, and reliance on fresh equity issuances, as well as insider share sales that have raised questions about management confidence and shareholder dilution. See our latest analysis for Quantum Computing. Those concerns have been playing out in the share price, with a 30 day share price return of a 36.61% decline and a 90 day share price return of a 30.36% decline. Even though the 3 year...

Koninklijke Heijmans N.V. recently reported its full-year 2025 results, with sales rising to €2,772 million and net income increasing to €130 million compared with the prior year. The sharp improvement in basic earnings per share from continuing operations, up to €4.73, underlines a step-up in profitability that may reshape how investors view Heijmans’ earnings power. We’ll now examine how Heijmans’ stronger full-year profitability could influence its pre-existing investment narrative around...

Corvus Pharmaceuticals (CRVS) has drawn attention after a sharp move in its share price, with the stock showing very large gains over the past month and the past 3 months. See our latest analysis for Corvus Pharmaceuticals. The latest share price of $17.38 comes after a steep recent run, with a 30 day share price return of 115.90% and a 90 day share price return of 95.28%. This has contributed to a year to date share price return of 137.43% and a 1 year total shareholder return of 264.36%,...

RenaissanceRe Holdings (NYSE:RNR) announced its 31st consecutive annual increase to its quarterly dividend. The company also renewed and expanded its share repurchase program, authorizing additional buybacks. Management reported that a meaningful portion of the authorization has already been used for recent share repurchases. RenaissanceRe Holdings is a global provider of reinsurance and insurance solutions, so its capital decisions tend to attract close attention from income and total...

The Trade Desk and THG Beauty Media have agreed a partnership that puts premium beauty commerce data from LOOKFANTASTIC and Cult Beauty into The Trade Desk’s Kokai platform.

Grupo Aeroméxico de (NYSE:AERO) closed out FY 2025 with Q4 revenue of US$1.4b and basic EPS of US$1.21, alongside net income of US$165.1m, setting a clear marker for how the year finished. Over the past year, the company has seen trailing twelve month revenue hold around US$5.4b with basic EPS at US$2.58, compared with US$5.6b of revenue and EPS of US$4.62 a year earlier. This gives investors a clean read on how the top line and EPS trend into the latest print. With a trailing net margin of...

If you are wondering whether Hecla Mining's recent share price puts it in bargain or fully priced territory, you are not alone. This article will walk through what the numbers actually say about its value. The stock has seen a 7.6% decline over the last week and a 20.0% decline over the last 30 days, yet it is still up 12.6% year to date and 282.9% over the last year, which can leave investors questioning what is already priced in. These swings have been accompanied by ongoing interest in...

Recent events around Kimberly-Clark (KMB) have drawn fresh attention, with two research firms reiterating positive views and company director Todd Maclin purchasing 10,000 shares, a transaction many investors watch for potential insider conviction. See our latest analysis for Kimberly-Clark. The recent analyst reaffirmations and insider purchase come after a mixed period for investors, with a 30 day share price return of 8.26% and year to date share price return of 6.04% contrasting with a 1...

If you are wondering whether PulteGroup at around US$141.58 is still good value after a strong run, this article walks through what the current price might be implying. The stock has recently recorded returns of 3.1% over 7 days, 8.7% over 30 days, 18.9% year to date, 35.1% over 1 year and 174.8% over 3 years. This naturally raises questions about both growth potential and changes in perceived risk. Recent coverage of US homebuilders has focused on how demand, supply constraints and...

The third-quarter results for RHI Magnesita India Limited ( NSE:RHIM ) were released last week, making it a good time...